Company Filing History:
Years Active: 2007-2015
Title: Erich Koller: Innovator in Antisense Drug Technology
Introduction
Erich Koller, based in Carlsbad, California, is a notable inventor with a remarkable portfolio of 10 patents to his name. His innovations primarily focus on improving the efficiency and effectiveness of antisense drugs, contributing significantly to the field of biomedical research.
Latest Patents
Koller's latest patents showcase his commitment to advancing antisense technology. One of his notable inventions, titled "Compounds and methods for improving cellular uptake of oligomeric compounds," presents methods that optimize the efficacy and potency of antisense drugs. Additionally, he developed a patent on "Antisense modulation of kinesin-like 1 expression," which includes compounds and methodologies for modulating the expression of kinesin-like 1, potentially aiding in the treatment of diseases linked to its expression. His work emphasizes the importance of enhancing oligonucleotide characteristics and excipients for improved cellular uptake.
Career Highlights
Throughout his career, Erich Koller has made significant contributions while working at various esteemed organizations, including Isis Pharmaceuticals, Inc. and Regulus Therapeutics Inc. His efforts have paved the way for innovations that impact drug development and therapeutic strategies in the field of molecular biology.
Collaborations
Koller's journey includes collaborations with distinguished individuals, such as Kenneth W. Dobie and C. Frank Bennett. These partnerships have allowed him to leverage diverse expertise and knowledge, fostering an environment ripe for innovation and advancement in pharmaceutical research.
Conclusion
In conclusion, Erich Koller stands out as a pivotal figure in the realm of antisense technology, with his patents reflecting a dedication to improving drug efficacy and cellular interactions. His work not only symbolizes his inventive spirit but also carries the potential to contribute meaningfully to medical advancements and therapies.